All three trials reported the proportion of people who successfully completed treatment for latent tuberculosis. Overall, education or counselling interventions may increase successful treatment completion but the magnitude of benefit is likely to vary depending on the nature of the intervention, and the setting (data not pooled, 923 participants, three trials, low quality evidence).
In a four-arm trial in children from Spain, counselling by nurses via telephone increased the proportion of children completing treatment from 65% to 94% (RR 1.44, 95% CI 1.21 to 1.72; 157 participants, one trial), and counselling by nurses through home visits increased completion to 95% (RR 1.46, 95% CI 1.23 to 1.74; 156 participants, one trial). Both of these interventions were superior to counselling by physicians at the tuberculosis clinic (RR 1.20, 95% CI 0.98 to 1.47; 159 participants, one trial).
In the USA, a programme of peer counselling for adolescents failed to show an effect on treatment completion rates at six months (RR 1.01, 95% CI 0.90 to 1.13; 394 participants, one trial). In this trial treatment completion was around 75% even in the control group.
In the third study, in prisoners from the USA, treatment completion was very low in the control group (12%), and although counselling significantly improved this, completion in the intervention group remained low at 24% (RR 1.94, 95% CI 1.03 to 3.68; 211 participants, one trial).
None of these trials aimed to assess the effect of these interventions on the subsequent development of active tuberculosis, and we found no trials that assessed the effects of patient education or counselling on adherence to treatment for active tuberculosis.
Authors' conclusions
Educational or counselling interventions may improve completion of treatment for latent tuberculosis. As would be expected, the magnitude of the benefit is likely to depend on the nature of the intervention, and the reasons for low completion rates in the specific setting.
P L A I N L A N G U A G E S U M M A R Y

Counselling and education interventions for promoting adherence to treatment for tuberculosis
Many people do not take their medication as prescribed. The consequences of this for chronic and debilitating infections like tuberculosis are serious and can include prolonged periods of infectiousness, relapse, emergence of drug-resistant Mycobacterium tuberculosis isolates, and increased morbidity and mortality. Our review considered trials of education and counselling in promoting adherence to the treatment of both latent (dormant) and active tuberculosis.
We identified three very low quality evidence trials involving a total of 1437 participants that evaluated education and counselling interventions in promoting adherence to completion of medication for treatment of latent tuberculosis. Two of these studies demonstrated a beneficial effect of education and counselling upon adherence to drug treatment, whereas one did not.
There were substantial differences between trials with respect to populations targeted, interventions chosen and outcomes measured. The existing evidence is insufficient to guide policy on the use of education and counselling to promote adherence to tuberculosis therapy.
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
In people requiring treatment for latent tuberculosis, does education/counselling improve treatment completion?
Patient or population: People with latent tuberculosis
Settings:
Low and high resources settings Intervention: Any educational or counselling intervention (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR:
Risk ratio;
GRADE Working Group grades of evidence High quality:
Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality:
Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality:
Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality:
We are very uncertain about the estimate.
1
Downgraded by 1 for risk of bias: Allocation concealment was not adequately described in any of the studies 2 Downgraded by 1 for inconsistency: The effects varied between the studies as would be expected with different populations and different interventions. However there was a positive effect in two studies and no effect in a single study in adolescents where completion was high (75%) in the control group. Tuberculosis treatment regimens can vary, but they generally require the use of multiple drugs for a minimum of six months (Harries 2004) . Regardless of which regimen is in place, patients often find it difficult to complete their course of drug treatment.
B A C K G R O U N D Description of the condition
Frequently they feel well after the first few months of treatment, when most of the tubercle bacilli have been killed, and stop taking the prescribed regimen of drugs. Personal factors (eg poor understanding of the disease or treatment requirements), drug side effects, drug resistance leading to protracted treatment periods, social and economic factors (eg stigma, lack of family support, and poverty), and health system factors (eg inconvenient treatment arrangements, poor patient-provider relationships, and nonavailability of drugs) can further contribute to poor adherence to treatment (Atkins 2010; Comolet 1998; Rideout 1994) . The consequences of not completing drug therapy are serious and can include a prolonged period of infectiousness, relapse, emergence of drug-resistant M. tuberculosis isolates, and increased morbidity and mortality. Poor adherence to drug treatment therefore poses a serious risk to the community and contributes to failure in eradicating the disease globally (Addington 1979; Cuneo 1989; Fox 1983; WHO 2006) . In high-risk groups, such as the homeless, intravenous drug users, people infected with HIV, and prisoners, completion of the drug treatment regimen poses special challenges. These groups contribute significantly to the global burden of tuberculosis and spread of the disease, and therefore warrant special attention within tuberculosis control and treatment programmes. People at high risk of developing clinical tuberculosis who require preventive therapy (also referred to as chemoprophylaxis or treatment of latent tuberculosis) constitute yet another group for whom adherence to treatment is important (Chaisson 2001; Sanmarti 1993) . The most common preventive therapy regimen is daily isoniazid for a period of 6 to 12 months, but other effective regimens also exist (Akolo 2010; Smieja 1999) . The choice of regimen will depend on factors such as cost, the likelihood of adverse effects, adherence and drug resistance. Treatment adherence can be defined as the extent to which people follow the instructions they are given regarding prescribed treatments. The term is intended to be non-judgemental, a statement of fact rather than one of blame. Various strategies have been employed in an attempt to improve adherence to tuberculosis treatment. Many of these strategies target patients (eg reminders and prompts, defaulter action, education and counselling, incentives and reimbursements, contracts, peer assistance, and directly observed therapy). Other interventions are directed at healthcare providers (eg staff motivation and supervision) or the mode of treatment delivery (eg intermittent dosing and drug packaging). 
Description of the intervention
Techniques used in delivering patient education cover a wide spectrum of means, including dissemination of information via the mass media, provision of written, audiovisual, and computerbased patient education materials by healthcare providers or institutions, and individualized counselling approaches. A number of interventions have been used to promote adherence. This Cochrane Review is one of several published, planned, or in progress to evaluate each type of intervention:
• Patient education and counselling: provision of information or one-to-one or group counselling about tuberculosis and the need to complete treatment (this review).
• Staff motivation and supervision: training and management processes that aim to improve how providers care for people with tuberculosis.
• Reminder systems and late patient tracers in the diagnosis and management of tuberculosis: routinely reminding patients to keep an appointment and actions taken when patients fail to keep an appointment (Liu 2008) .
• Incentives and reimbursements: money or cash to reimburse expenses of attending services, or to improve the attractiveness of visiting the service.
• Contracts: written or verbal agreements to return for an appointment or course of treatment (Bosch-Capblanch 2007) .
• Peer assistance: people from the same social group helping someone with tuberculosis return to the health service by prompting or accompanying them.
• Directly observed therapy (DOT): an appointed agent (health worker, community volunteer, family member) directly monitors people swallowing their antituberculous drugs (Volmink 2007).
• Material incentives and enablers in the management of tuberculosis (Lutge 2012).
How the intervention might work
Patient education and counselling aims to ensure that people have sufficient knowledge and understanding to make informed choices and actively participate in their own health care. In this review, we evaluated the impact of these interventions on adherence to drug treatment for active and latent tuberculosis. Patient education has been defined as a deliberate process of influencing patient behaviour and producing the changes in knowledge, attitudes, and practices necessary to maintain or improve health (AAFP 2000) . Providing patients with complete and current information about their health helps create an atmosphere of trust, enhances the healthcare provider-patient relationship, and empowers patients to participate in their own health care. In this review, counselling refers to one-on-one or group interaction between the study participant(s) and a trained counsellor with the aim of providing tailored guidance and problem-solving skills to help patients manage their health problem better. During the counselling sessions, attempts are made to understand the patient's level of understanding of tuberculosis and its treatment, and also explore any misconceptions. Emphasis is put on the tuberculosis infection, the importance of therapy and adherence to therapy, the possible adverse effects, and dietary habits. It is assumed that gains made at this level would be further strengthened during subsequent visits through education sessions.
Why it is important to do this review
Patient education and counselling strategies have been shown to improve treatment outcomes for certain conditions (Haynes 2008). However, their value for people with tuberculosis is unclear. Non-adherence to drug treatment for tuberculosis has the potential to impact negatively on both the individual patient and on the broader health of the community. It is therefore important to evaluate which interventions are effective in supporting adherence and completion of tuberculosis drug treatment regimens.
O B J E C T I V E S
The objectives of this review are to evaluate the effects of education or counselling, or both, on:
1. treatment completion and cure in people with clinical tuberculosis.
2. treatment completion and the incidence of clinical tuberculosis in people receiving antituberculosis preventive therapy.
M E T H O D S Criteria for considering studies for this review
Types of studies
Randomized controlled trials (where the unit of randomization was the individual or a cluster).
Types of participants
• Adults and children receiving treatment for active tuberculosis. Active tuberculosis is defined as having sputum smear-positive sample, sputum culture-positive sample, or if negative for the latter two, typical tuberculosis clinical findings coupled with radiographic assessment reports (WHO 2008).
• Adults and children at risk of acquiring active tuberculosis (those with positive tuberculin skin test) who were receiving medication for prevention of the disease (chemoprophylaxis or treatment of latent tuberculosis).
Types of interventions Intervention
Any educational or counselling intervention alone or in combination with each other aimed at improving adherence to antituberculous treatment or preventive chemotherapy. Trials in which education or counselling or both interventions were confounded by other types of interventions were excluded.
Control
Any alternative educational or counselling intervention, or 'no educational or counselling intervention' or 'usual care'.
Types of outcome measures Primary outcomes
Treatment for active tuberculosis:
• Cure (for smear positive): defined as negative sputum smears in the last month of treatment and on at least one previous occasion.
• Adherence as measured by treatment completion (defined as completion of the antituberculous treatment and not classifiable as either cure or treatment failure, with failure taken to be a positive smear at five months or later during treatment).
Preventive therapy
• Incidence of active tuberculosis: based upon microbiological diagnosis, histological diagnosis, or as a defined clinical syndrome by the trial authors.
• Adherence as measured by treatment completion or as defined by trial authors.
Secondary outcomes
Treatment of active tuberculosis:
• Incidence of resistance to antituberculous treatment, as reported by trial authors.
• Death from any cause during the treatment period.
Preventive therapy:
• Interval to active tuberculosis from initiation of preventive therapy.
Search methods for identification of studies
We attempted to identify all relevant trials regardless of language or publication status (published, unpublished, in press, and in progress). We searched the following databases using the search terms and strategy described in We searched the metaRegister of Controlled Trials (mRCT) using 'tuberculosis', 'education', 'counselling', and 'adherence' as search terms. We contacted researchers, authors of included trials, and other experts in the field of tuberculosis and adherence research. We also contacted relevant organizations, including the WHO, Centers for Disease Control and Prevention (CDC), Tuberculosis Trials Consortium (TBTC), International Union Against Tuberculosis and Lung Disease (IUATLD), and the Stop TB Partnership, for unpublished and ongoing trials.
We checked the reference lists of all studies identified by the above methods.
Data collection and analysis
Selection of studies
We independently screened all citations and abstracts identified by the search strategy for potentially eligible studies. Subsequently, we used the titles and abstracts of the identified studies to exclude trials that clearly did not meet the inclusion criteria. We independently assessed the full text articles of potentially relevant trials using a pre-specified trial inclusion criteria based on the study design features, type of participants, and features of interventions and controls. If a study's eligibility was unclear, we contacted the study authors for clarification. We excluded studies that did not meet the inclusion criteria and documented the reasons for exclusion in the Characteristics of excluded studies table. We resolved any differences in opinion through discussion.
Data extraction and management
Using a pre-designed data extraction form, we independently extracted data from the selected trials. For each of the trials, the data we extracted included: methods, participant characteristics, interventions, and outcomes. For dichotomous outcomes, we extracted the number of participants with the event of interest, the number randomized to each group, and the number analysed for each trial. Where study findings were uncertain or missing, we contacted trial authors for clarification and details. We resolved any differences in opinion through discussion.
Assessment of risk of bias in included studies
We independently assessed the risk of bias of each trial using a predesigned assessment form based on sequence generation (randomization); allocation concealment; blinding of participants, personnel and outcome assessors; completeness of outcome data; selective reporting; and other potential threats to internal validity. For each risk of bias component, we classified each trial as 'unclear', 'yes', or 'no', corresponding with an unclear, low, or high risk of bias respectively, as described in Higgins 2008. The results of the assessment are summarized in the risk of bias table of Characteristics of included studies and Figure 1 and Figure 2 . Where necessary, we contacted the authors of assessed trials for clarification. We resolved any differences in opinion through discussion. 
Measures of treatment effect
We calculated risk ratios (RRs) with 95% confidence intervals (CI) for dichotomous data.
Dealing with missing data
We present the results of the studies individually using an available case analysis. We also conducted a best and worst case scenario to explore the effect of the missing data (losses to follow-up) on the results for the only reported primary outcome, adherence.
Assessment of heterogeneity
We assessed heterogeneity by comparing patient and trial characteristics. The included trials were both clinically and methodologically variable. The populations in the three trials included children, adolescents and prisoners all having different issues for adherence. The peer counselling and educational interventions also differed substantially, and therefore we did not conduct a metaanalysis and statistical heterogeneity is not reported.
Assessment of reporting biases
Statistical assessment of potential publication bias was not possible given the small number of eligible studies.
Data synthesis
Data analysis was conducted using Review Manager 5. We considered it inappropriate to pool the results of the three included studies given the substantial clinical and methodological heterogeneity. The findings were therefore reported narratively.
Subgroup analysis and investigation of heterogeneity
We had planned to perform subgroup analysis, with subgroups defined by the age, sex, and HIV status (positive/negative) of study participants, country income level (low-, middle-, and high-income), and type of education or counselling, or both used. However, due to the small number of studies included in the review, we could not investigate heterogeneity using subgroups as previously planned.
R E S U L T S Description of studies
See: Characteristics of included studies; Characteristics of excluded studies; Characteristics of studies awaiting classification; Characteristics of ongoing studies. Figure 3 shows the summary of the trial selection process. Centres for Disease Control and Prevention guidelines focusing on latent tuberculosis therapy, adverse effects, availability of free care after release, and location of, transportation to, and hours of the tuberculosis clinic. In Sanmarti 1993, education consisted of discussions on the importance and need for chemoprophylaxis and re-issuing informative leaflets, and was delivered to mothers by a specialized nurse through telephone calls or home visits, or by a physician at the tuberculosis clinic. In Morisky 2001, education and counselling interventions based on a pre-prepared protocol were provided by specially trained peer counsellors.
Results of the search
Outcomes
Preventative therapy
Incidence of active tuberculosis:
No studies measured the interval to active tuberculosis from initiation of preventive therapy.
Adherence:
Adherence measures were dichotomous in all the three studies. White 2002 assessed completion of the first visit to the tuberculosis clinic scheduled for one month after release from jail and completion rate of isoniazid at six months. Sanmarti 1993, evaluated clinic attendance at the final visit at 12 months, as well as the presence of positive Eidus-Hamilton reaction in the urine at that visit. Morisky 2001 measured adherence by completion of the course of isoniazid after six months, measured using the discharge summary in the patient's medical chart.
Treatment for active tuberculosis
No studies included patients on treatment for active tuberculosis.
Excluded studies
Sixteen studies that initially seemed to fit the inclusion criteria were eventually excluded from our review. The reasons for exclusion are provided in the Characteristics of excluded studies table.
The most common reasons for exclusion were the presence of confounding interventions and inappropriate study designs (ie nonrandomized clinical trials).
Risk of bias in included studies
The summary of risk of bias is shown in Figure 1 and Figure 2 .
Allocation
White 2002 used an adequate method for generating the allocation sequence − a table of random numbers. The remaining two trial reports (Morisky 2001 and Sanmarti 1993) did not provide information on generation of allocation sequence and this aspect of the study was therefore judged as unclear. Allocation concealment, intended to prevent investigators from anticipating and influencing which group the participants might be allocated to, was unclear in all the three included studies as the process was not adequately described.
Blinding
Participants, personnel and assessors were not blinded in any of the included trials.
Incomplete outcome data
Outcome reporting was adequate in two trials (Sanmarti 1993; Morisky 2001) and inadequate in (White 2002) (see Characteristics of included studies for details of individual studies).
Selective reporting
We were unable to access the protocols for the studies and have judged the reporting of outcomes as 'unclear'. However, there was no clear evidence of selective reporting in the included studies and all of the outcomes specified in the trials methods sections have been reported.
Other potential sources of bias
In one of the trials (Sanmarti 1993), participants in the experimental groups were contacted or seen every three months (thus, received additional attention) and an Eidus-Hamilton reaction was performed at every visit, in addition to receiving the educational interventions. These additional interventions, which were not received by participants in the control group, could have introduced confounding. (195) . The total percentage of randomized participants included in the analysis was 96.6% (767/794).The analysis was described as an intention-totreat analysis, whereby all patients who did not have a measure for completion of care were assumed to have discontinued therapy and were coded as having not completed care. The authors then referred to exceptions in which patients whose treatment was discontinued by the physician, or who informed the clinics that they were moving, were analysed differently. It is unclear whether these patients were excluded from the analysis or were considered to have completed care. The results that are reported do not include all 794 initially randomized patients, and is therefore likely a modified intention-to-treat analysis. There was no statistically significant difference reported between the peer counselling and usual care groups. In a best case scenario, assuming that all those lost to follow up in either group did complete therapy, there was no significant difference between the peer counselling group (166/ 199) 
Effects of interventions
Treatment for active tuberculosis
D I S C U S S I O N Summary of main results
There is very low quality evidence that in children at risk of tuberculosis, treatment adherence (as measured by attendance at the clinic at one year) is improved by mothers receiving an educational intervention delivered by nurses by telephone or by a home visit (Sanmarti 1993). Another study found that prison inmates receiving an educational intervention were more likely to complete treatment for latent tuberculosis than those who do not (White 2002) . There is no evidence that peer counselling improves completion of treatment in adolescents with latent tuberculosis (Morisky 2001).
Overall completeness and applicability of evidence
We did not find any eligible studies of patient education and counselling for promoting adherence to treatment in patients with active tuberculosis. The three trials of participants with latent tuberculosis were conducted in the USA and Spain. The evidence base currently does not include participants living in low resource countries or those in special risk groups, such as HIV-infected patients, intravenous drug users, the homeless, and others. Furthermore, to avoid high risk of bias we excluded a number of studies that did not meet our inclusion criteria, as described under Characteristics of excluded studies. A key issue with the application of an educational and counselling intervention is the possible cost implications, particularly in settings already poorly resources in terms of staff or funds. A costeffectiveness study linked with Morisky 2001 described the direct costs of the counselling intervention relative to standard of care (Kominsky 2007) . Direct costs included clinic visits, mantoux testing, chest X-rays, costs of staffing and hiring of peer counsellors, and travel to the clinic for the patient. The usual cost of care in this American setting was $199, whereas the addition of peer counselling increased the cost to $277. It is difficult to extrapolate from this study the possible costs in other settings, particularly in low-and middle-income settings where tuberculosis is most prevalent. However, this gives a good indication that the intervention would add costs, both in terms of human resources and necessary funding. The current data is insufficient to provide a relevant costbenefit assessment. Decision makers aiming to implement educational programmes based on evidence from other settings would have to consider the additional costs.
Quality of the evidence
Overall, the GRADE quality of evidence for the outcomes assessed was rated as 'very low' and highlights the need for further large randomized controlled trials of education and counselling in people on drug treatment for active or latent tuberculosis. Figure 2 ). The sample sizes of the included trials were relatively small. Small trials are more likely than larger trials to be insufficiently powered to detect clinically and statistically significant differences between groups. Poor quality trials are more likely to be subject to bias and therefore the results are less reliable than those from better quality trials (Schulz 1995).
A U T H O R S ' C O N C L U S I O N S Implications for practice
There is very low quality evidence that education or counselling or both promotes adherence to treatment for latent tuberculosis. We found no studies that examined the effectiveness of education or counselling or both interventions for improving adherence in patients with active tuberculosis.
There is therefore insufficient evidence to recommend the widespread use of education and counselling in tuberculosis services. Future efforts may need to look at the effectiveness and benefits of these interventions as there is some evidence in other disease conditions (Haynes 2008).
Implications for research
There is a need for adequately powered, good quality, randomized controlled trials that evaluate education and counselling in people with latent and active tuberculosis. These studies should be designed to assess the effects of the interventions on the important clinical outcomes such as cure or tuberculosis incidence in participants living in countries with a high burden of tuberculosis. It may be more relevant to evaluate education and counselling as part of packages of care or interventions that support adherence.
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C H A R A C T E R I S T I C S O F S T U D I E S Characteristics of included studies [ordered by study ID]
Morisky 2001
Methods Randomized controlled trial; parallel group design. Duration: 6 months (1995 through 1998: recruitment and data collection) Participants Number enrolled: 794 Number available for analysis: 767 Inclusion criteria: Latent tuberculosis Exclusion criteria: Active tuberculosis Method of screening/confirmation: not indicated
Interventions
Peer counselling: Specially trained adolescent peer counsellors who had previously completed treatment for latent tuberculosis, following a standardized protocol, contacted by telephone all participants assigned to them one week after commencement of treatment and at least every two weeks thereafter. The initial contact aimed to establish rapport and explain the role of the peer educator, and stressed the importance of clinic attendance and medication-taking. Later contacts focused on addressing beliefs, problems or concerns Parent-participant contingency contract: With the assistance of program staff, parents and adolescents negotiated an incentive provided by the parent to be received if the adolescent adhered to the prescribed tuberculosis treatment ie keeping appointments with tuberculosis clinic and taking the tuberculosis medication every day Combined use of peer counselling and incentives: Received both peer counselling and parent-participant contingency contract interventions Control (Usual Care): Received all of the treatment and educational services usually provided by the clinic, eg face-to face health education from tuberculosis staff and assessment and health checks in response to treatment. All participants received US $15 as reimbursement for their time spent completing the baseline and post-test interviews. All participants were also interviewed three times during the six months of their treatment Outcomes Treatment adherence measured by treatment completion as reported in the participant's discharge medical summary.
Notes Location: USA Setting: Two public clinics in Los Angeles, California, both serving large numbers of adolescents receiving care for latent tuberculosis infection Results of contingency contract and combined arms not reported in this review
Risk of bias
Bias
Authors' judgement Support for judgement
Random sequence generation (selection bias)
Unclear risk "Participants were randomly assigned to one of four intervention groups". It is unclear how this was done Interventions Education by nurse via telephone: Mothers were telephoned by specialized nursing personnel every three months, who informed them of the advantages of chemoprophylaxis for their child's health and encouraged them to continue with this preventive measure Education by nurse via home visit: Specialized nurse visited the participant's home every three months, providing health education to mother and child, encouraging them to continue with the preventive therapy, and re-issuing informative leaflets given at the first visit. Also, the Eidus-Hamilton reaction was performed to objectively verify compliance with the therapy. Possible adverse reactions were monitored Education by doctor at clinic: The child was seen by the physician every three months at the Tuberculosis Prevention and Control Centre. At each visit, the doctor gave educational messages to both mother and child, provided the same informative leaflets given at the first visit, monitored possible drug adverse reactions, and performed the EidusHamilton reaction Education messages were standardized through use of the same health education script by both the physician and the nurses, and participants were given the same pamphlets Control group: No health education activity was performed. After the first visit, the Sanmarti 1993 (Continued) mothers were informed that unless they considered it appropriate there was no need to come back until after they had followed the treatment for 12 months At recruitment, all the groups received the following: Parents were told how their children had to take isoniazid and given informative leaflets regarding tuberculosis and its prevention. They were also informed what symptoms to look for and to see the doctor if they suspected the existence of any of these symptoms or if they considered it advisable For all the groups, the final visit consisted of medical history and examination, a chest X-ray and the performance of the Eidus-Hamilton reaction Allocation concealment (selection bias) Unclear risk Subjects were randomized using ordered sealed envelopes containing the allocation.
Megias 1990 (Continued)
Intervention 2: Education by nurse via home visit: A follow-up visit every three months from a nurse who explained the advantages of the treatment and left some explanatory pamphlets. The nurse also tested the patient's urine using the Eldus-Hamilton reaction to check if treatment was being followed Intervention 3: Education by doctor at clinic: Each participant was given an appointment to be examined by a doctor every three months. During the follow-up, the doctor provided the same information, pamphlets included, as for group 2, and tested the patient's urine with the Eldus-Hamilton reaction Control group (routine care): Participants were not given any educational materials or information during the twelve months of the study. Other than the first visit, they were not seen again until the end of the study 12 months later, when their urine was tested by the Eldus-Hamilton reaction To standardise educational messages imparted by the doctors and nurses, a health education guide was used Participants in all comparison groups received a prescription for isoniazid prophylaxis at recruitment (1) This study was in children in Spain, follow-up was 12 months.
(2) This study was in adolescents in the USA, follow-up 6 months (3) This study was in prisoners being released from jail, follow-up 6 months 
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